Douglas Lind

Douglas Lind

Active Investor

Chief Executive Officer at Apik Bio

New York City, New York

Douglas Lind, Chief Executive Officer at Apik Bio is an active investor based in New York City, New York. This profile covers what Douglas Lind backs, at which stage, and how founders can reach out in 2026.

Investor type
VCMicro VC
Stages
SeedSeries ASeries B
Invests in
FintechLending & CreditHealthcare & BiotechDigital Health & HealthTechBiotech & PharmaMedTech & Medical DevicesSaaS & EnterpriseConsumer & Retail
Location
New York City, New York
Typical check
$1M
Past investments
12

Notable investments

Burrill & CompanyMabVax TherapeuticsBetterDoctorBioMark CapitalFlexible Stenting SolutionsHyperMed Imaging, Inc.WaveTec VisionADMA Biologicsi2DxLentigenJHL BiotechWhiteGlove Health

How to reach Douglas Lind

Angels and operators like Douglas Lind reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded.

Frequently Asked Questions

What does Douglas Lind invest in?

Douglas Lind invests in Fintech, Lending & Credit, Healthcare & Biotech and Digital Health & HealthTech, typically at Seed, Series A and Series B. Match your sector and stage, then reach out with a personalized pitch.

How do I contact Douglas Lind?

Unlock Douglas Lind's verified email on Round Funded and send a personalized pitch. We surface only deliverable contacts so your outreach lands.

Similar investors

Browse all investorsIs this you? Email team@roundfunded.com to update or remove your profile.